Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Clinical trial NCT03020303 · COMPLETED

Trial details

NCT number: NCT03020303
Sponsor: Hamilton Health Sciences Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Endstage Renal Disease

Start date: 2017-07-07
Primary completion: 2025-03-14
Enrollment: 2538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.